Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Opioids in the Transition From Acute to Chronic Opioid Use
NCT07211399Phase 1Withdrawn
- Start
- Jul 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine and ketamine in opioid use disorder (OUD) (2 arms). Primary endpoints: PACU Opioid Medication Administered at 5 days, PACU Non-Opioid Medication Administered at 5 days and 2 more. Planned start Jul 2026; status: withdrawn.
02
Drugs
dexmedetomidineketamine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07211399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211399.